28 October 2025
GSK’s B7-H3-targeted antibody-drug conjugate, GSK’227, receives Orphan Drug Designation in the EU GSK plc (LSE/NYSE: GSK) today announced that GSK5764227 (GSK’227), its B7-H3-targeted antibody-drug conjugate…
B.P. Marsh & Partners Plc (“B.P. Marsh”, “the Company” or “the Group”) Sale of Stewart Specialty Risk Underwriting Limited B.P. Marsh & Partners Plc…
27 October 2025
LSEG and Anthropic collaborate to make more financial dataaccessible to Claude for Enterprise customers LSEG today announced a collaboration with Anthropic granting access to…
24 October 2025
Blenrep approved by US FDA for use in treatment of relapsed/refractory multiple myeloma GSK plc (LSE/NYSE: GSK) today announced the US Food and Drug Administration…
23 October 2025
B.P. Marsh & Partners Plc (“B.P. Marsh”, “the Company” or “the Group”) Half Year Results B.P. Marsh & Partners Plc (AIM: BPM), the specialist…
SOFTCAT plc (‘Softcat’, the ‘Group’) Preliminary results for the year ended 31 July 2025 Another record performance, alongside investment in future growth Softcat plc…
20 October 2025
THE MERCANTILE INVESTMENT TRUST PLC HALF YEAR REPORT & FINANCIAL STATEMENTS FOR THE SIX MONTHS ENDED31ST JULY 2025 Legal Entity Identifier: 549300BGX3CJIHLP2H42 Information disclosed…
2 October 2025
Unilever PLC Separation of Unilever’s Ice Cream Business – Publication of Shareholder Circular On 19 March 2024, Unilever PLC (“Unilever“) announced its intention to…